STATEMENT: 3P Biopharmaceuticals shows its commitment against Covid-19

We are living in difficult times due to the COVID19 pandemic, and it is in these times of serious difficulty that 3P Biopharmaceuticals shows its maximum commitment to its employees and to society.

Therefore, 3P Biopharmaceuticals makes its capabilities and knowledge available to the Spanish Health Authorities as well as companies in the pharmaceutical and biotechnology sector in order to address this problem in the most diligent manner possible.

As a manufacturer of next generation drugs and vaccines, and therefore a strategic company for the management of this crisis, we are making every effort to maintain our activity for the good of our employees, clients, partners, and society, always safeguarding the well-being and safety of our employees to the maximum level.

We have a highly committed team of professionals who are fully aware that working in the development of medicines can contribute in a tangible way to solving this crisis, contributing the best of themselves in these days where the only option is unifying to win this battle.

Maintaining our activity is the best social contribution that we can provide to our society. Our society needs us, you need us.

3P Closer than ever

[Spanish version below]

COMUNICADO

Estamos viviendo tiempos difíciles debido a la pandemia de Coronavirus y es en estos tiempos de seria dificultad donde 3P Biopharmaceuticals muestra su máximo compromiso con sus empleados y con la sociedad. Por tanto, 3P Biopharmaceuticals pone sus capacidades y conocimiento a disposición de las autoridades sanitarias y compañías del sector farmacéutico y biotecnológico para tratar el problema de la manera mas diligente posible.

Como fabricante de medicamentos y vacunas de ultima generación y por tanto compañía estratégica para la gestión de esta crisis estamos realizando el máximo esfuerzo para mantener nuestra actividad por el bien de nuestros empleados, clientes, socios y la sociedad, salvaguardando al máximo el bienestar y seguridad de nuestros empleados.

Contamos con un equipo de profesionales altamente comprometido y plenamente consciente de que trabajando en el desarrollo de medicamentos contribuyen de manera tangible a resolver esta crisis, aportando lo mejor de sí mismos en estos días donde solo cabe sumar para ganar la batalla.

Mantener nuestra actividad es el mejor bien social que podemos aportar a nuestra sociedad. Nuestra sociedad nos necesita, tú nos necesitas.

3P Closer than ever

Related Content

3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis.

Published: 19th September 2023
Toleranzia is at the forefront of innovation with their groundbreaking candidate, TOL2, designed to address the autoimmune neuromuscular disease, Myasthenia Gravis (MG).
Read more

3P Biopharmaceuticals lands in the United States.

Published: 8th June 2023
The Navarre biological CDMO inaugurates its first commercial office in Boston, supported by Keensight Capital.
Read more

3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease.

Published: 2nd May 2023
The process transfer and GMP supply of the FGF-1 candidate have been achieved successfully by both companies.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.